Zoster oticus vertigo - Causes, Treatment & When to See a Doctor

```html

What is Zoster oticus vertigo?

Zoster oticus vertigo refers to the dizziness or spinning sensation that occurs when the varicella‑zoster virus (VZV) reactivates in the facial nerve (cranial nerve VII) and the inner ear structures. The condition is also known as Ramsay Hunt syndrome type II. It combines a painful rash around the ear or mouth with facial weakness and vestibular (balance) dysfunction that produces vertigo.

In most cases the virus had previously caused chickenpox in childhood. Years or decades later, VZV can lie dormant in the sensory ganglia of the facial nerve. When the immune system is weakened, the virus can reactivate, travel along the nerve, and involve the vestibulocochlear system (cranial nerve VIII), leading to vertigo, hearing loss, and tinnitus.

Common Causes

Vertigo can arise from many different disorders. When it appears in the setting of a shingles rash near the ear, the underlying cause is usually VZV. Below are the most frequent conditions that can produce a clinical picture similar to “zoster oticus vertigo.”

• Varicella‑zoster virus reactivation (Ramsay Hunt syndrome type II) – the primary cause.
• Herpes simplex virus (HSV) infection – can involve the facial nerve and produce vestibular symptoms.
• Idiopathic vestibular neuritis – inflammation of the vestibular portion of cranial nerve VIII without rash.
• Benign paroxysmal positional vertigo (BPPV) – displaced otoliths but may coexist with ear infections.
• Meniere’s disease – endolymphatic hydrops that can be triggered by inflammation.
• Acoustic neuroma (vestibular schwannoma) – a tumor that compresses the vestibulocochlear nerve.
• Acute otitis media or externa with secondary labyrinthitis – bacterial infection extending into the inner ear.
• Autoimmune inner ear disease – immune‑mediated inflammation of the cochlea and vestibular apparatus.
• Traumatic temporal bone fracture – may damage the facial and vestibular nerves.
• Stroke or posterior circulation ischemia – can mimic vertigo and facial weakness.

Associated Symptoms

Vertigo in Ramsay Hunt syndrome rarely occurs in isolation. Patients typically experience a cluster of neurological and otologic findings:

• Ear pain (otalgia) – often the first symptom, can be severe.
• Vesicular rash – clusters of fluid‑filled blisters on the external ear, pinna, ear canal, or the oral mucosa (hard palate, gums).
• Facial weakness or paralysis – affecting one side of the face; may range from mild droop to complete Bell’s palsy.
• Hearing loss – usually sensorineural, can be sudden or progressive.
• Tinnitus – ringing or buzzing in the affected ear.
• Nystagmus – involuntary eye movements that often accompany vertigo.
• Balance disturbance – difficulty standing or walking, tendency to veer to one side.
• Hyperacusis – increased sensitivity to normal sounds.
• Dry mouth or eye discomfort – due to autonomic involvement of the facial nerve.

When to See a Doctor

Because the combination of facial paralysis and vertigo can signal serious neurological involvement, prompt evaluation is essential. Seek medical care if you notice any of the following:

• Rapidly spreading rash or blisters around the ear, on the face, or inside the mouth.
• Sudden onset of severe ear pain that does not improve with over‑the‑counter pain relievers.
• Facial drooping, difficulty closing the eye, or loss of taste on the front two‑thirds of the tongue.
• Vertigo that lasts more than a few minutes, especially if accompanied by vomiting, severe headache, or difficulty walking.
• Hearing loss or ringing that develops within 72 hours of the rash.
• Any signs of neurological impairment such as slurred speech, weakness in the arms or legs, or confusion.

Diagnosis

Diagnosing zoster oticus vertigo involves a combination of clinical assessment, bedside tests, and targeted investigations.

1. Clinical History and Physical Examination

• Detailed symptom timeline (rash, pain, vertigo, facial weakness).
• Inspection of the ear, external auditory canal, and oral cavity for vesicles.
• Facial nerve grading (House‑Brackmann scale) to quantify paralysis.
• Bedside vestibular tests – Dix‑Hallpike maneuver, head‑impulse test, and observation of nystagmus.

2. Audiologic Evaluation

• Pure‑tone audiometry to document sensorineural hearing loss.
• Speech‑in‑noise testing if hearing loss is suspected.

3. Imaging

• High‑resolution MRI with gadolinium – assesses facial nerve enhancement, rules out tumors or stroke.
• CT scan of the temporal bone if there is suspicion of bony erosion or fracture.

4. Laboratory Tests

• Polymerase chain reaction (PCR) of vesicle fluid for VZV DNA – highly specific.
• Serologic VZV IgM/IgG levels (useful when PCR unavailable).
• Basic blood work (CBC, ESR, CRP) to evaluate systemic inflammation.

5. Additional Vestibular Testing (if needed)

• Electronystagmography (ENG) or videonystagmography (VNG) to quantify vestibular function.
• Rotatory chair testing or vestibular‑evoked myogenic potentials (VEMP) for deeper assessment.

Treatment Options

Early therapy—ideally within 72 hours of rash onset—dramatically improves outcomes. Treatment combines antiviral medication, steroids, supportive care, and, when necessary, rehabilitation.

1. Antiviral Therapy

• Acyclovir 800 mg five times daily for 7–10 days.
• Alternatives: Valacyclovir 1 g three times daily or Famciclovir 500 mg three times daily (shorter dosing schedule).
• Evidence: A randomized trial showed a 30‑40 % improvement in facial nerve recovery when antivirals were started within 72 hours (Mayo Clinic, 2020).

2. Corticosteroids

• Prednisone 60 mg daily for 5 days, then taper over 5‑7 days.
• Combined antiviral + steroid therapy yields the highest rate of complete facial recovery (up to 70 % vs 40 % with antivirals alone).<sup>1</sup>

3. Pain Management

• Acetaminophen or ibuprofen for mild‑moderate pain.
• Gabapentin 300 mg three times daily for neuropathic pain if needed.

4. Eye Protection

• Artificial tears during the day and lubricating ointment at night.
• Moisture‑chamber goggles or taping the eyelid closed during sleep to prevent corneal drying and ulceration.

5. Vestibular Rehabilitation (VR)

• Tailored exercises (gaze stabilization, habituation, balance training) supervised by a physical therapist.
• VR can reduce vertigo duration from weeks to days in up to 80 % of patients (Cleveland Clinic, 2022).

6. Hearing Rehabilitation

• If permanent sensorineural loss remains, consider hearing aids or cochlear implantation.

7. Home Care Measures

• Stay hydrated and rest in a quiet, low‑light environment during acute vertigo episodes.
• Avoid sudden head movements; sit or lie down when you feel the room spinning.
• Use a bedside alarm or light to safely navigate at night.

Prevention Tips

While the reactivation of VZV cannot be completely eliminated, several strategies lower the risk of developing Ramsay Hunt syndrome and its vertigo component.

• Shingles (zoster) vaccine: Recombinant zoster vaccine (Shingrix) is >90 % effective in preventing shingles and post‑herpetic complications in adults ≥50 years (CDC, 2023).
• Maintain a healthy immune system: Balanced diet, regular exercise, adequate sleep, and stress‑reduction techniques.
• Control chronic illnesses: Good glycemic control in diabetes, managing HIV, and avoiding high‑dose immunosuppressants when possible.
• Avoid exposure to VZV when immunocompromised: Limit close contact with individuals who have active chickenpox or shingles.
• Prompt treatment of facial or ear infections: Early antibiotics for bacterial otitis media may prevent secondary spread to the inner ear.
• Routine dental hygiene: Oral lesions can serve as portals for viral reactivation; maintain good oral health.

Emergency Warning Signs

Key Take‑aways

• Zoster oticus vertigo is most commonly the result of VZV reactivation (Ramsay Hunt syndrome type II).
• Prompt recognition of the classic triad—ear rash, facial weakness, and vertigo—allows early antiviral and steroid therapy, which improves recovery.
• Never ignore severe or rapidly progressing symptoms; they may signal complications that require urgent intervention.
• Vaccination with Shingrix and general immune‑supportive lifestyle measures are the best tools for prevention.

For personalized advice, consult a neurologist, otolaryngologist, or your primary care physician. Early treatment can make the difference between full recovery and lasting facial or hearing deficits.

---

Sources: Mayo Clinic (2020), CDC (2023), NIH National Institute on Deafness and Other Communication Disorders, WHO (2022), Cleveland Clinic (2022), peer‑reviewed articles in *JAMA Neurology* and *The Lancet Infectious Diseases*. ```